Refarmed Chemicals SA Farma Industria Ticino

Refarmed Chemicals SA

Address

Via G. Ferri 15
6904 Lugano

Phone

+41 91 960 50 80

Links

www.refarmed.ch
[email protected]

Social

Refarmed Chemicals, part of the DKSH Group, is a Swiss company with extensive experience in the pharmaceutical industry, specializing in the international distribution of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs), with integrated expertise in commercial operations, regulatory affairs, and supply chain management.

Our global presence, supported by an established network of qualified manufacturing partners and dedicated sourcing teams in India and China, enables our customers to benefit from our expertise in API sourcing, as well as in the development of finished formulations and new products.

In addition, Refarmed offers a range of value-added services, including regulatory and technical support, supply chain management, logistics services, identification and qualification of manufacturing partners, and business development activities.

With an established international presence and commercial operations in over 60 markets, Refarmed benefits from a strong global network of customers and partners, enabling the company to stay abreast of developments in the pharmaceutical industry and support business growth worldwide.

Through a project-driven business model, Refarmed combines the distribution of APIs and finished pharmaceutical products with specialized consulting services, regulatory support, business development, and co-development activities throughout the entire product lifecycle.

Activities

Main Activity

Licensing-In
Licensing-Out
Development
Co-development
Trading
Drug Product CMO (Partial)
Drug Substance CMO (Partial)
Drug commercialization
API Manufacturing (Partial)
Other Activities

Therapeutic Areas

Cancer supportive therapy
Cardiology
CNS
Dermatology
Endocrinology/Diabetes
Gastrointestinal
Gynaecology/Women's Health
Infertility
Infectious diseases
Anesthesia
Mental health
Metabolism
Oncology
Ophthalmology
Orthopedics
Pain
Respiratory
Rheumatology
Urology
Other therapeutic areas (Partial)

Markets

CH
EU Top 5
Rest of Europe
USA and Canada
Japan
LATAM
MENA
BRICS
ASEAN
Australia (Partial)

Drug Stages

Registration (Partial)
Market (Partial)
Generic Plus (505B2)
Generic
Life cycle management (Partial)

Drug Product Forms

Injectable (Partial)
Oral (solid) (Partial)
Oral (liquid) (Partial)
Topical (Partial)

Certifications

Swissmedic
FDA (Partial)
European Medicines Agency (Partial)

ESG Certifications & Collaborations

Ecovadis